MISTY SUMMERS: Open Payments
NPI 1134634371 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 37 payments from 10 companies in 2025. Trend: 2023 $597 · 2024 $1,037 · 2025 $857
Food & beverage: $757Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $362 |
| Regeneron Healthcare Solutions, Inc. | 9 | $141 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $100 |
| Amgen Inc. | 4 | $84 |
| Janssen Biotech, Inc. | 3 | $68 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| Incyte Corporation | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: SKYRIZI, DUPIXENT, OTEZLA, TREMFYA, LIBTAYO, PURIFIED CORTROPHIN GEL, OPZELURA, Zoryve.
Industry payments across VA — which companies pay providers there.
